Fast monocyte-derived dendritic cell-based immunotherapy

Ramadan, Gamal;

Abstract


© Springer Science+Business Media New York 2014. Recent reports have described a new strategy for differentiation and maturation of monocyte (Mo)-derived dendritic cells (DC) within only 48-72 h of in vitro culture (fast-DC). Mature fast-DC are as effective as mature standard-DC (generated in 7-10 days of in vitro culture) in priming and propagation of antigenspecific T-cell responses. The use of fast-DC not only reduces labor and supply cost, as well as workload and time, but also increases the DC yield from Mo, which may facilitate DC-based immunotherapy for cancer patients. Detailed protocols for generation, pulsing with different antigen sources, and transduction with adenoviral vector of Mo-derived mature fast-DC as well as using of fast-DC for priming and propagation of antigen-specifi c cytotoxic T-cell effectors will be described here.


Other data

Title Fast monocyte-derived dendritic cell-based immunotherapy
Authors Ramadan, Gamal 
Issue Date 1-Jan-2014
Journal Methods in Molecular Biology 
DOI 131
http://api.elsevier.com/content/abstract/scopus_id/84909580806
1139
1940-6029
10.1007/978-1-4939-0345-0_12
PubMed ID 1139
Scopus ID 2-s2.0-84909580806

Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

Citations 3 in scopus
views 10 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.